Hartis-Pharma is a Swiss-based biotech company with clinical-stage ready compound in Sickle Cell Disease (SCD). We aim to develop treatments against diseases and disease complications due to decreased HDL functions.
Hartis-Pharma is a Swiss-based biotech company with clinical-stage ready compound in Sickle Cell Disease (SCD). We aim to develop treatments against diseases and disease complications due to decreased HDL functions.